Abstract:Abstract Background Obesity is an epidemic disease in the world, the treatment and prevention of obesity methods have gained great attention. Lactobacillus is the main member of probiotics, and the physiological activity of it is specific to different strains. This study systematically explored the anti-obesity effect and possible mechanism of Lactobacillus fermentum CQPC07 (LF-CQPC07), which was isolated from pickled vegetables. Results LF-CQPC07 effectively controlled the weight gain of mice caused by a high-fat diet. The results of pathological sections indicated that LF-CQPC07 alleviated hepatocyte damage and fat accumulation in adipocytes. The detection of biochemical indictors revealed that LF-CQPC07 decreased the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and triglycerides (TG), and increased the level of high-density lipoprotein cholesterol (HDL-C). Additionally, LF-CQPC07 caused the decrease in the amounts of inflammatory cytokines interleukin (IL)-1β, tumor necrosis factor-α (TNF-α), IL-6, and interferon-γ (IFN-γ), and the increase in the amounts of the anti-inflammatory cytokines IL-10 and IL-4. LF-CQPC07 also decreased the amounts of alanine aminotransferase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP). Confirmed by qPCR, LF-CQPC07 enhanced the mRNA expression of catalase (CAT), gamma glutamylcysteine synthetase 1 (GSH1), copper/zinc superoxide dismutase (SOD1), manganese superoxide dismutase (SOD2), and glutathione peroxidase (GSH-Px). It also increased the mRNA expression levels of carnitine palmitoyltransferase 1 (CPT1), peroxisome proliferator-activated receptor alpha (PPAR-α), lipoprotein lipase (LPL), and cholesterol 7 alpha hydroxylase (CYP7A1), and decreased that of PPAR-γ and CCAAT/enhancer binding protein alpha (C/EBP-α) in the liver of mice. Conclusion This research confirmed that LF-CQPC07 is capable of ameliorating obesity, improving hyperlipemia, and alleviating chronic low-grade inflammation and liver injury accompanied with obesity. Its mechanism may be the regulation of antioxidant capacity and lipid metabolism. Therefore, LF-CQPC07 has enormous potential to serve as a potential probiotic for the prevention or treatment of obesity.

Transcriptomics Reveals the Anti-Obesity Mechanism of Lactobacillus Plantarum Fermented Barley Extract

Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 Decreased Fat Accumulation of Caenorhabditis Elegans in a Daf-2-dependent Mechanism.

Lactobacillus Plantarum Dy-1 Fermented Barley Extraction Activates White Adipocyte Browning in High-Fat Diet-Induced Obese Rats.

Fermented barley extracts with Lactobacillus plantarum dy-1 decreased fat accumulation of Caenorhabditis elegans in a daf-2-dependent mechanism

Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 Changes Serum Metabolomic Profiles in Rats with High-Fat Diet-Induced Obesity.

Anti-obesity Action of Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 and Associated MicroRNA Expression in High-fat Diet-induced Obese Rats

Antiobesity Effect of Lactiplantibacillus Plantarum Fermented Barley Extracts Via the Interactions with Gut Microbiota of the Obese Adult Humans

Supplementation of Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 Inhibits Obesity Via a UCP1-dependent Mechanism.

Liubao Tea Extract Restrains Obesity-Related Hyperlipidemia Via Regulation of AMPK/p38/NF-κB Pathway and Intestinal Microbiota

Lactiplantibacillus Plantarum Fermented Barley Extracts Ameliorate High-Fat-diet-induced Muscle Dysfunction Via Mitophagy

Dietary Supplementation with Lactobacillus Plantarum Dy-1 Fermented Barley Suppresses Body Weight Gain in High-Fat Diet-Induced Obese Rats.

Metabolomics Reveal the Regulatory Effect of Polysaccharides from Fermented Barley Bran Extract on Lipid Accumulation in HepG2 Cells

The Anti-Obesity Effect of Fermented Barley Extracts with Lactobacillus Plantarum Dy-1 and Saccharomyces Cerevisiae in Diet-Induced Obese Rats.

Barley Protein LFBEP-C1 from Lactiplantibacillus plantarum dy-1 Fermented Barley Extracts by Inhibiting Lipid Accumulation in a Caenorhabditis elegans Model

Metabolomics reveals the effects of<i> Lactiplantibacillus</i><i> plantarum</i> dy-1 fermentation on the lipid-lowering capacity of barley 13-glucans in an<i> in</i><i> vitro</i> model of gut-liver axis

Metabolites of Clostridium leptum fermenting flaxseed polysaccharide alleviate obesity in rats

Lactobacillus fermentum CQPC07 attenuates obesity, inflammation and dyslipidemia by modulating the antioxidant capacity and lipid metabolism in high-fat diet induced obese mice

Lactobacillus plantarum alleviates high-fat diet-induced obesity by altering the structure of mice intestinal microbial communities and serum metabolic profiles

Lactobacillus plantarum Alleviates Obesity by Altering the Composition of the Gut Microbiota in High-Fat Diet-Fed Mice

Fermented Barley Β‐glucan Regulates Fat Deposition in Caenorhabditis Elegans

Metabolomics Reveals the Effects of Lactiplantibacillus Plantarum Dy-1 Fermentation on the Lipid-Lowering Capacity of Barley Β-Glucans in an in Vitro Model of Gut-Liver Axis.